Task: Answer the multiple-choice question.
Question: Which compound exhibits a -28.826% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cc1ccc(-c2nnn(CC(=O)N3CCN(c4ccccc4)CC3)n2)o1
b: Cc1ccc(C)c(S(=O)(=O)N2CCN(C(=O)CSc3ccccc3)CC2)c1
Answer: b. Cc1ccc(C)c(S(=O)(=O)N2CCN(C(=O)CSc3ccccc3)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(C)c(S(=O)(=O)N2CCN(C(=O)CSc3ccccc3)CC2)c1
Cc1ccc(C)c(S(=O)(=O)N2CCN(C(=O)CSc3ccccc3)CC2)c1
1-[4-(2,5-dimethylphenyl)sulfonylpiperazin-1-yl]-2-phenylsulfanylethanone